Hypervirulent Klebsiella pneumoniae causing emphysematous pyelonephritis: a life-threatening pathogen within Australian communities

IF 6.8 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Medical Journal of Australia Pub Date : 2024-11-22 DOI:10.5694/mja2.52540
Katherine GC Ong, John R Dyer, Dickon Hayne
{"title":"Hypervirulent Klebsiella pneumoniae causing emphysematous pyelonephritis: a life-threatening pathogen within Australian communities","authors":"Katherine GC Ong,&nbsp;John R Dyer,&nbsp;Dickon Hayne","doi":"10.5694/mja2.52540","DOIUrl":null,"url":null,"abstract":"<p><b><i><span>In reply</span></i></b>: We thank Bowyer and Prentice for their input<span><sup>1</sup></span> regarding our article<span><sup>2</sup></span> on this interesting and complex topic.</p><p>We agree with the definition of emphysematous pyelonephritis and emphysematous cystitis as described by Bowyer and Prentice. There was indeed gas evident within our patient's left renal collecting system, as shown on a computed tomography scan, which was not included in our published article as we felt that the other published images would be of more interest to readers.</p><p>We agree that sodium–glucose cotransporter type 2 (SGLT2) inhibitors cause glycosuria and have been implicated in an increased risk of urinary tract infections.<span><sup>3, 4</sup></span> Our patient had been taking an SGLT2 inhibitor, which was ceased during his first admission.</p><p>The occasional association of intestinal strongyloidiasis with gram-negative sepsis and, in particular, gram-negative bacillary meningitis, is well recognised. However, strongyloidiasis was not suspected in our patient, and diagnostic tests for this pathogen were not performed.</p><p>No relevant disclosures.</p>","PeriodicalId":18214,"journal":{"name":"Medical Journal of Australia","volume":"222 1","pages":"53"},"PeriodicalIF":6.8000,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.5694/mja2.52540","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of Australia","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.5694/mja2.52540","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

In reply: We thank Bowyer and Prentice for their input1 regarding our article2 on this interesting and complex topic.

We agree with the definition of emphysematous pyelonephritis and emphysematous cystitis as described by Bowyer and Prentice. There was indeed gas evident within our patient's left renal collecting system, as shown on a computed tomography scan, which was not included in our published article as we felt that the other published images would be of more interest to readers.

We agree that sodium–glucose cotransporter type 2 (SGLT2) inhibitors cause glycosuria and have been implicated in an increased risk of urinary tract infections.3, 4 Our patient had been taking an SGLT2 inhibitor, which was ceased during his first admission.

The occasional association of intestinal strongyloidiasis with gram-negative sepsis and, in particular, gram-negative bacillary meningitis, is well recognised. However, strongyloidiasis was not suspected in our patient, and diagnostic tests for this pathogen were not performed.

No relevant disclosures.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
引起气肿性肾盂肾炎的高病毒性肺炎克雷伯氏菌:澳大利亚社区中威胁生命的病原体。
回复:我们感谢Bowyer和Prentice对我们这篇关于这个有趣而复杂的话题的文章所提供的意见。我们同意Bowyer和Prentice对气肿性肾盂肾炎和气肿性膀胱炎的定义。在我们的患者左肾收集系统内确实有明显的气体,如计算机断层扫描所示,这并没有包括在我们发表的文章中,因为我们认为其他发表的图像会让读者更感兴趣。我们同意钠-葡萄糖共转运蛋白2型(SGLT2)抑制剂引起糖尿症,并与尿路感染风险增加有关。3,4我们的患者一直在服用SGLT2抑制剂,在他第一次入院时停止使用。肠类棒状线虫病与革兰氏阴性败血症,特别是革兰氏阴性细菌性脑膜炎的偶尔关联是公认的。然而,我们的病人没有怀疑类圆线虫病,也没有进行这种病原体的诊断试验。无相关披露。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medical Journal of Australia
Medical Journal of Australia 医学-医学:内科
CiteScore
9.40
自引率
5.30%
发文量
410
审稿时长
3-8 weeks
期刊介绍: The Medical Journal of Australia (MJA) stands as Australia's foremost general medical journal, leading the dissemination of high-quality research and commentary to shape health policy and influence medical practices within the country. Under the leadership of Professor Virginia Barbour, the expert editorial team at MJA is dedicated to providing authors with a constructive and collaborative peer-review and publication process. Established in 1914, the MJA has evolved into a modern journal that upholds its founding values, maintaining a commitment to supporting the medical profession by delivering high-quality and pertinent information essential to medical practice.
期刊最新文献
Stigmatising Attitudes Towards People With Depression, Bipolar Disorder, Borderline Personality, ADHD and Early and Long-Term/Untreated Schizophrenia: Representative Survey of Australian Adults Worsening Asthma Outcomes in Australian Adults: A Comparison of Stratified Sample Surveys in 2012 and 2021 Continuity of Care in General Practice in Australia: A Whole-Of-Population Serial Cross-Sectional Study Short-Term Safety and Adverse Event Risk Profiles for SARS-CoV-2 Booster Vaccine Doses in Australian Adults: A Survey Study Hospital-Admitted Injection-Related Infections Among Incarcerated People Who Inject Drugs in Australia: A Retrospective Cohort Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1